Optimax Holdings Berhad (OPTIMAX) Stock Overview
An investment holding company, engages in the provision of eye specialist services and related products in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
OPTIMAX Community Fair Values
See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Optimax Holdings Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.54 |
| 52 Week High | RM 0.71 |
| 52 Week Low | RM 0.49 |
| Beta | 0.14 |
| 1 Month Change | 0% |
| 3 Month Change | -11.57% |
| 1 Year Change | 8.08% |
| 3 Year Change | -26.71% |
| 5 Year Change | -30.52% |
| Change since IPO | 56.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPTIMAX | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 1.9% | -1.3% | 0.9% |
| 1Y | 8.1% | 23.7% | 12.6% |
Return vs Industry: OPTIMAX underperformed the MY Healthcare industry which returned 23.7% over the past year.
Return vs Market: OPTIMAX underperformed the MY Market which returned 12.6% over the past year.
Price Volatility
| OPTIMAX volatility | |
|---|---|
| OPTIMAX Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in MY Market | 11.6% |
| 10% least volatile stocks in MY Market | 2.8% |
Stable Share Price: OPTIMAX has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: OPTIMAX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Sandy Tan | www.optimax2u.com |
Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company’s specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services.
Optimax Holdings Berhad Fundamentals Summary
| OPTIMAX fundamental statistics | |
|---|---|
| Market cap | RM 290.67m |
| Earnings (TTM) | RM 13.75m |
| Revenue (TTM) | RM 135.80m |
Is OPTIMAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPTIMAX income statement (TTM) | |
|---|---|
| Revenue | RM 135.80m |
| Cost of Revenue | RM 81.46m |
| Gross Profit | RM 54.34m |
| Other Expenses | RM 40.59m |
| Earnings | RM 13.75m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.025 |
| Gross Margin | 40.01% |
| Net Profit Margin | 10.13% |
| Debt/Equity Ratio | 24.2% |
How did OPTIMAX perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/20 12:00 |
| End of Day Share Price | 2026/04/20 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Optimax Holdings Berhad is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Wo Chen Weng | CGS International |
| Chee Siang | Hong Leong Investment Bank Berhad |
| null null | JF Apex Securities Berhad |